Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis

ClinicalTrials.gov ID: NCT03020719

Public ClinicalTrials.gov record NCT03020719. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis

Study identification

NCT ID
NCT03020719
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of Minnesota
Other
Enrollment
60 participants

Conditions and interventions

Interventions

  • Oral Glutathione Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
2 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 13, 2017
Primary completion
Dec 11, 2018
Completion
Dec 11, 2018
Last update posted
Jan 8, 2020

2017 – 2018

United States locations

U.S. sites
18
U.S. states
14
U.S. cities
18
Facility City State ZIP Site status
Childrens Hospital Colorado Aurora Colorado 80045
Connecticut Childrens Medical Center Hartford Connecticut 06107
Nemours Childrens Clinic Jacksonville Florida 32207
Nemours Children's Clinic Pensacola Florida 32504
Emory University Hospital Atlanta Georgia 30324
Riley Children's Hospital Indianapolis Indiana 46202
Childrens Hospital of Michigan Detroit Michigan 48201
Helen DeVos Women and Childrens Center Grand Rapids Michigan 49503
University of Minnesota Medical Center Minneapolis Minnesota 55414
The Childrens Mercy Hospital Kansas City Missouri 64108
Women and Childrens Hospital of Buffalo Buffalo New York 14222
Childrens Hospital of New York/Columbia University Medical Center New York New York 10032
Oregon Health & Science University Portland Oregon 97239
UT Southwestern Medical Center Dallas Texas 75390
Baylor College of Medicine Houston Texas 77030
The University of Vermont Inc. Burlington Vermont 05401
University of Virginia Health System Charlottesville Virginia 22908
Childrens Hospital of Milwaukee Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03020719, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 8, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03020719 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →